Plain-English translation of NCT07112989 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting tumor tissue and blood samples from patients diagnosed with sarcomas (cancers of bone or soft tissue) or cancers that have spread to the bones or lungs. Researchers will use these samples to build innovative laboratory models—think of them as miniature versions of your tumor grown in a lab—that can be used to test how different treatments work.
Doctors need better ways to predict which treatments will work for each patient's cancer and which ones might cause harmful side effects. By creating patient-specific laboratory models, researchers hope to identify new drug targets and develop more effective treatment strategies tailored to individual tumors.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo your planned surgery or biopsy as usual. During that procedure, your doctor will collect a small extra sample of tumor tissue and blood that would otherwise not be used. You won't need additional visits or procedures—the sample collection happens at the same time as your standard care. Your samples will then be sent to the research laboratory where scientists will develop and test different laboratory models using your tissue.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
Italy
Sponsor
Istituto Ortopedico Rizzoli
Enrollment target
~125 participants
Started
September 2024
Primary completion
September 2031
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Toni Ibrahim, MD Oncologist
Istituto Ortopedico Rizzoli
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.